These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31032220)

  • 1. Hepatoma-Derived Growth Factor and DDX5 Promote Carcinogenesis and Progression of Endometrial Cancer by Activating β-Catenin.
    Liu C; Wang L; Jiang Q; Zhang J; Zhu L; Lin L; Jiang H; Lin D; Xiao Y; Fang W; Guo S
    Front Oncol; 2019; 9():211. PubMed ID: 31032220
    [No Abstract]   [Full Text] [Related]  

  • 2. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 3. ZEB1 promotes invasion and metastasis of endometrial cancer by interacting with HDGF and inducing its transcription.
    Xiao YY; Lin L; Li YH; Jiang HP; Zhu LT; Deng YR; Lin D; Chen W; Zeng CY; Wang LJ; Chen SC; Jiang QP; Liu CH; Fang WY; Guo SQ
    Am J Cancer Res; 2019; 9(11):2314-2330. PubMed ID: 31815037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
    Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
    Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAP1L1 Promotes Endometrial Cancer Progression via EP300-Mediated DDX5 Promoter Acetylation.
    Zhu X; Li Y; Shao Z; Lu X; Chen Y
    Mol Cancer Res; 2024 Nov; 22(11):1011-1021. PubMed ID: 38953887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma.
    Tang J; Shi H; Li H; Zhen T; Dong Y; Zhang F; Yang Y; Han A
    Tumour Biol; 2016 Aug; 37(8):10287-301. PubMed ID: 26842923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAP1L1 promotes the growth of colon cancer by activating HDGF/DDX5.
    Liang X; Tang Z; Zhang Y; Sun Y; Wang J
    Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1234-1243. PubMed ID: 36148951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis.
    Cheng C; Li W; Peng X; Liu X; Zhang Z; Liu Z; Deng T; Luo R; Fang W; Deng X
    Mol Ther Methods Clin Dev; 2021 Mar; 20():615-624. PubMed ID: 33718512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-939 Directly Targets
    Situ J; Zhang H; Jin Z; Li K; Mao Y; Huang W
    Onco Targets Ther; 2020; 13():4257-4270. PubMed ID: 32547060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complex mechanism for HDGF-mediated cell growth, migration, invasion, and TMZ chemosensitivity in glioma.
    Song Y; Hu Z; Long H; Peng Y; Zhang X; Que T; Zheng S; Li Z; Wang G; Yi L; Liu Z; Fang W; Qi S
    J Neurooncol; 2014 Sep; 119(2):285-95. PubMed ID: 24986090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
    Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH
    Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer.
    Ma Z; Feng J; Guo Y; Kong R; Ma Y; Sun L; Yang X; Zhou B; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Cheng Y; Zha D; Liu S
    Oncol Res; 2017 Jul; 25(6):887-895. PubMed ID: 28244855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
    Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
    J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Curcumin suppresses invasiveness and migration of human glioma cells in vitro by inhibiting HDGF/β-catenin complex].
    Luo Q; Luo H; Fu H; Huang H; Huang H; Luo K; Li C; Hu R; Zheng C; Lan C; Tang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Aug; 39(8):911-916. PubMed ID: 31511210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway.
    Xue Y; Jia X; Li L; Dong X; Ling J; Yuan J; Li Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2885-2891. PubMed ID: 30119889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer.
    Xiaohua Zhu ; Xie Y; Huang W; Chen Z; Guo S
    BMC Cancer; 2022 Mar; 22(1):339. PubMed ID: 35351053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
    Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
    J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-873 inhibits the proliferation and invasion of endometrial cancer cells by directly targeting hepatoma-derived growth factor.
    Wang Q; Zhu W
    Exp Ther Med; 2019 Aug; 18(2):1291-1298. PubMed ID: 31363373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
    Yang F; Yu N; Wang H; Zhang C; Zhang Z; Li Y; Li D; Yan L; Liu H; Xu Z
    PLoS One; 2018; 13(1):e0190725. PubMed ID: 29300772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.